Siri Drangsholt1, Maria Juliana Arcila Ruiz2, Benoit Peyronnet3, Nirit Rosenblum2, Victor Nitti2, Benjamin Brucker2. 1. Department of Urology, New York University School of Medicine, 222 E 41st St 11th Floor, New York, 10017, NY, USA. siri.drangsholt@nyumc.org. 2. Division of Female Pelvic Medicine and Reconstructive Surgery, New York University Langone Health, 222 E 41st St 11th Floor, New York, 10017, NY, USA. 3. Department of Urology, Service D'Urologie, University of Rennes, 2 Rue Henri Le Guilloux, 35000, Rennes, France.
Abstract
OBJECTIVE: To characterize the current evaluation, and efficacy of treatments in patients with the primary complaint of nocturia. METHODS: A retrospective chart review was performed of new patient encounters seen in a tertiary urology practice from May 2010 to September 2016 with the primary diagnosis of nocturia (ICD-9 788.43 and ICD-10 R35.1). RESULTS: 595 patients were identified. 403 met inclusion criteria. The median patient reported that nocturia episodes were 4 (1-20). 192 patients (48%) reported previous treatment for nocturia. After the index visit, a bladder diary (BD) was utilized in 50% of patients, with a 62% (n = 124) completion rate at follow-up visit. On BD analysis, the most common etiologies of nocturia were nocturnal polyuria 76% (n = 90) and overactive bladder in 21% (n = 26). Patient reported improvement with therapy after BD completion was 46% (n = 34), similar to patients without voiding diaries (43% improvement, n = 153). Anticholinergics and alpha blockers were the most commonly recommended drug, but no specific medication was associated with nocturia improvement. Oral desmopressin was used in 5% of patients. CONCLUSION: Nocturia is a common condition and very commonly patients have sought treatment prior to presentation. Bladder diaries were recommended to half of the patients. Patient reported that improvement did not seem to correlate with completion of a bladder diary. Though most patients had NP the use of desmopressin was very low. Current treatments used in managing nocturia may lack efficacy.
OBJECTIVE: To characterize the current evaluation, and efficacy of treatments in patients with the primary complaint of nocturia. METHODS: A retrospective chart review was performed of new patient encounters seen in a tertiary urology practice from May 2010 to September 2016 with the primary diagnosis of nocturia (ICD-9 788.43 and ICD-10 R35.1). RESULTS: 595 patients were identified. 403 met inclusion criteria. The median patient reported that nocturia episodes were 4 (1-20). 192 patients (48%) reported previous treatment for nocturia. After the index visit, a bladder diary (BD) was utilized in 50% of patients, with a 62% (n = 124) completion rate at follow-up visit. On BD analysis, the most common etiologies of nocturia were nocturnal polyuria 76% (n = 90) and overactive bladder in 21% (n = 26). Patient reported improvement with therapy after BD completion was 46% (n = 34), similar to patients without voiding diaries (43% improvement, n = 153). Anticholinergics and alpha blockers were the most commonly recommended drug, but no specific medication was associated with nocturia improvement. Oral desmopressin was used in 5% of patients. CONCLUSION:Nocturia is a common condition and very commonly patients have sought treatment prior to presentation. Bladder diaries were recommended to half of the patients. Patient reported that improvement did not seem to correlate with completion of a bladder diary. Though most patients had NP the use of desmopressin was very low. Current treatments used in managing nocturia may lack efficacy.
Entities:
Keywords:
Desmopressin; Frequency volume chart; Nocturia; Nocturnal polyuria
Authors: Philip van Kerrebroeck; Paul Abrams; David Chaikin; Jenny Donovan; David Fonda; Simon Jackson; Poul Jennum; Theodore Johnson; Gunnar Lose; Anders Mattiasson; Gary Robertson; Jeff Weiss Journal: Neurourol Urodyn Date: 2002 Impact factor: 2.696
Authors: Theodore M Johnson; Karen Jones; William O Williford; Michael H Kutner; Muta M Issa; Herbert Lepor Journal: J Urol Date: 2003-07 Impact factor: 7.450
Authors: Jean-Nicolas Cornu; Paul Abrams; Christopher R Chapple; Roger R Dmochowski; Gary E Lemack; Martin C Michel; Andrea Tubaro; Stephan Madersbacher Journal: Eur Urol Date: 2012-07-20 Impact factor: 20.096
Authors: Philip van Kerrebroeck; Masoumeh Rezapour; Ariane Cortesse; Joachim Thüroff; Anders Riis; Jens Peter Nørgaard Journal: Eur Urol Date: 2007-01-16 Impact factor: 20.096
Authors: Kari A O Tikkinen; Theodore M Johnson; Teuvo L J Tammela; Harri Sintonen; Jari Haukka; Heini Huhtala; Anssi Auvinen Journal: Eur Urol Date: 2009-04-03 Impact factor: 20.096
Authors: Benoit Peyronnet; Lauren B Krupp; W Stuart Reynolds; Xavier Gamé; Gérard Amarenco; Jean-Nicolas Cornu; Lana Zhovtis Ryerson; Carrie Lyn Sammarco; Jonathan E Howard; Robert W Charlson; Roger R Dmochowski; Benjamin M Brucker Journal: Rev Urol Date: 2019